Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinghao Pengbo, formally known as Beijing Xinghao Pengbo Pharmaceutical Technology, is a specialized research and development subsidiary of Beijing Xinghao Pharmaceutical. Based in Beijing, the company functions as a high-tech platform focused on pharmaceutical formulation innovation and CMC (Chemistry, Manufacturing, and Controls) services. Its core expertise lies in the development of complex delivery systems, including orally disintegrating tablets, sustained-release formulations, and solubilization technologies for poorly soluble drugs. Xinghao Pengbo provides comprehensive support throughout the drug development lifecycle, from pre-clinical research to clinical trial material production and regulatory filing. By integrating advanced manufacturing capabilities with rigorous R&D, the company serves as a critical engine for its parent group's expansion into high-end generic and innovative drug markets. The company is recognized for its ability to bridge the gap between laboratory-scale innovation and commercial-scale production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xinghao Pengbo.